Vascular localization of the 11β-hydroxysteroid dehydrogenase type II enzyme

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 6-7, 1996, Pages 549-551

  Smith, Robin E ^a   Little, Peter J ^a   Maguire, Julie A ^a   Stein Oakley, Alicia N ^a   Krozowski, Zygmunt S ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

11 hydroxysteroid dehydrogenase; glucocorticoid; mineralocorticoid; steroid; vasculature

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE;

ARTERIOLE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LOCALIZATION; HEART MUSCLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; SAPHENOUS VEIN; SKIN BLOOD VESSEL; TISSUE DISTRIBUTION; VASCULAR SMOOTH MUSCLE;

EID: 0029934634     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb02776.x     Document Type: Conference Paper

References (10)

1. Krozowski ZS, Funder JW. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc. Natl Acad. Sci. USA 1983; 80: 6056-60.
2. Edwards CR, Stewart PM, Burt D et al. Localisation of 11 beta-hydroxysteroid dehydrogenase: Tissue specific protector of the mineralocorticoid receptor. Lancet 1988; ii: 986-9.
3. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated. Science 1988; 242: 583-5.
4. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endocrinol. 1994; 105: R11-17.
5. Krozowski Z, Maguire JA, Stein-Oakley AN, Dowling J, Smith RE, Andrews RK. Immunohistochemical localization of the II beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J. Clin. Endocrinol. Metab. 1995; 80: 2203-9.
6. Wilson RC, Krozowski ZS, Li K et al. A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 1995; 80: 2263-6.
7. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nature Genet. 1995; 10: 394-9.
8. m 11beta-hydroxysteroid dehydrogenase type II enzyme in a family with apparent mineralocorticoid excess. J Clin. Endocrinol. Metab. 1995; 80: 3381-3.
9. Funder JW, Pearce PT, Smith R, Campbell J. Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors. Endocrinology 1989; 125: 2224-6.
10. Ullian ME, Walsh LG. Corticosterone metabolism and effects on angiotensin II receptors in vascular smooth muscle. Circ. Res. 1995; 77: 702-9.